Affinia Therapeutics Wins Canada Nod for AFTX-201 Trial
Waltham, Massachusetts, USA, April 6, 2026 Health Canada Approval Marks Key Clinical Milestone In a significant development for cardiovascular...
AFTX-201
Advertisement
Advertisement
